by santereshealth | Mar 16, 2021 | CMP News
The Draft Screening Assessment for the Ethers Group was published for a 60-day public comment period ending on May 12, 2021. Available here.
by santereshealth | Mar 10, 2021 | CMP News
The draft screening assessment and risk management scope for the Aliphatic Amines Group was published for a 60-day public comment period ending on May 5, 2021. Available here.
by santereshealth | Mar 10, 2021 | CMP News
The draft screening assessment and risk management scope for the Benzotriazoles and Benzothizoles Group was published for a 60-day public comment period ending on May 5, 2021. Available here.
by santereshealth | Mar 10, 2021 | CMP News
The draft screening assessment and risk management scope for the Hexamethylenetetramines Group was published for a 60-day public comment period ending on May 5, 2021. Available here.
by santereshealth | Mar 10, 2021 | CMP News
The Science Approach Document for the Bioactivity Exposure Ratio: Application in Priority Setting and Risk Assessment was released for a 60-day public comment period ending on May 5, 2021. Available here.
by santereshealth | Mar 9, 2021 | CMP News
The proposed order adding Chlorhexidine and its salts to Schedule 1 of the Canadian Environmental Protection Act, 1999 was published for a 60-day public comment period ending on May 5, 2021. AVAILABLE HERE
Recent Comments